Cargando…
Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139666/ http://dx.doi.org/10.1186/1471-2253-14-S1-A13 |
_version_ | 1782331391767216128 |
---|---|
author | Fiszer, Dorota Fisher, Nickla A Carr, Ian M Shaw, Marie-Anne Hopkins, Philip M |
author_facet | Fiszer, Dorota Fisher, Nickla A Carr, Ian M Shaw, Marie-Anne Hopkins, Philip M |
author_sort | Fiszer, Dorota |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4139666 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41396662014-08-22 Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility Fiszer, Dorota Fisher, Nickla A Carr, Ian M Shaw, Marie-Anne Hopkins, Philip M BMC Anesthesiol Oral Presentation BioMed Central 2014-08-18 /pmc/articles/PMC4139666/ http://dx.doi.org/10.1186/1471-2253-14-S1-A13 Text en Copyright © 2014 Fiszer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Oral Presentation Fiszer, Dorota Fisher, Nickla A Carr, Ian M Shaw, Marie-Anne Hopkins, Philip M Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility |
title | Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility |
title_full | Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility |
title_fullStr | Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility |
title_full_unstemmed | Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility |
title_short | Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility |
title_sort | advantage from massive parallel sequencing of ryr1 and cacna1s in diagnostics of malignant hyperthermia susceptibility |
topic | Oral Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139666/ http://dx.doi.org/10.1186/1471-2253-14-S1-A13 |
work_keys_str_mv | AT fiszerdorota advantagefrommassiveparallelsequencingofryr1andcacna1sindiagnosticsofmalignanthyperthermiasusceptibility AT fishernicklaa advantagefrommassiveparallelsequencingofryr1andcacna1sindiagnosticsofmalignanthyperthermiasusceptibility AT carrianm advantagefrommassiveparallelsequencingofryr1andcacna1sindiagnosticsofmalignanthyperthermiasusceptibility AT shawmarieanne advantagefrommassiveparallelsequencingofryr1andcacna1sindiagnosticsofmalignanthyperthermiasusceptibility AT hopkinsphilipm advantagefrommassiveparallelsequencingofryr1andcacna1sindiagnosticsofmalignanthyperthermiasusceptibility |